Ischaemic heart disease Clinical Trials

12 recruitingLast updated: June 18, 2026

There are 12 actively recruiting ischaemic heart disease clinical trials across 9 countries. Studies span Not Applicable, Phase 3. Top locations include Alicante, Alicante, Spain, Ashford, United Kingdom, Basildon, United Kingdom. Updated daily from ClinicalTrials.gov.


Ischaemic heart disease Trials at a Glance

12 actively recruiting trials for ischaemic heart disease are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Alicante, Ashford, and Basildon. Lead sponsors running ischaemic heart disease studies include Australia and New Zealand Cardiothoracic Surgery cardiac surgery database program, Hull University Teaching Hospitals NHS Trust, and Austin Health.

Browse ischaemic heart disease trials by phase

Treatments under study

About Ischaemic heart disease Clinical Trials

Looking for clinical trials for Ischaemic heart disease? There are currently 18 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischaemic heart disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischaemic heart disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

iCorMicA - Stratified Medicine in Angina

Coronary Artery DiseaseCoronary Microvascular Dysfunction (CMD)Angina, Stable+7 more
NHS Greater Glasgow and Clyde1,500 enrolled39 locationsNCT04674449
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Cardiorespiratory FitnessAcute Myocardial InfarctionAngina, Stable+3 more
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting

Machine Learning in Quantitative Stress Echocardiography

Cardiovascular DiseasesIschaemic heart disease
Hull University Teaching Hospitals NHS Trust1,250 enrolled1 locationNCT04193475
Recruiting

Optical Coherence Tomography Assessment of Radial Artery Injuries Caused by Trans-Radial Access

Radial artery injuryIschaemic heart disease
Austin Health50 enrolled1 locationACTRN12626000075381
Recruiting
Not Applicable

CABGpreHAB - a Feasibility Study Protocol

PrehabilitationAdultCoronary Artery Bypass+3 more
Rigshospitalet, Denmark50 enrolled1 locationNCT07035171
Recruiting

iFR Guided Coronary Artery Bypass Grafting Surgery

Coronary Artery DiseaseCoronary StenosisIschaemic heart disease
Prakash Punjabi100 enrolled1 locationNCT04014140
Recruiting

The “New predictiVe factors that drIve coronary atheroscleroSIs follOwiNg Coronary Artery Disease (VISION-CAD)” study

AtherosclerosisCardiovascularIschaemic heart disease
South Australian Health and Medical Research Institute300 enrolled3 locationsACTRN12623000458639
Recruiting
Phase 3

The effect of Colchicine on Cardiovascular Outcomes in Acute Coronary Syndrome Study (The COLCARDIO-ACS Study)

AtherosclerosisIschaemic heart disease
University of Sydney3,000 enrolled16 locationsACTRN12616000400460
Recruiting

A Randomised Control Trial for Advance Care Planning and Symptom Management for patients identified in the emergency department and followed up at home

Advanced progressive life-threatening illnesseslife-threatening malignancyprogressive neuro-degenerative disorders+3 more
Prince of Wales Hospital500 enrolled1 locationACTRN12614000590662
Recruiting

Aged Residential Care Healthcare Implementation Project (ARCHIP)

Congestive cardiac failureDeathStroke+4 more
University of Auckland400 enrolled1 locationACTRN12614000499684
Recruiting

Prophylactic intra-aortic balloon counterpulsation in high-risk cardiac surgery: An inception cohort study

High-risk cardiac surgeryIschaemic heart disease
Australia and New Zealand Cardiothoracic Surgery cardiac surgery database program250 enrolled4 locationsACTRN12613000293763
Recruiting

Take Heart in Primary Care Study

Comorbid depressionChronic ischaemic heart disease
NHMRC604 enrolled1 locationACTRN12606000371594